- Home
- PACB
as 05-30-2025 4:00pm EST
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | MENLO PARK |
| Market Cap: | 364.2M | IPO Year: | 2010 |
| Target Price: | $2.34 | AVG Volume (30 days): | 9.9M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.85 - $2.72 | Next Earning Date: | 05-08-2025 |
| Revenue: | $152,357,000 | Revenue Growth: | -23.98% |
| Revenue Growth (this year): | 4.67% | Revenue Growth (next year): | 19.09% |
Stock Insider Trading Activity of Pacific Biosciences of California Inc. (PACB)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Farmer Michele | PACB | See Remarks | May 19 '25 | Sell | $1.00 | 5,195 | $5,200.20 | 269,259 | |
| Farmer Michele | PACB | See Remarks | Mar 3 '25 | Sell | $1.41 | 2,973 | $4,183.01 | 269,259 | |
| Van Oene Mark | PACB | See Remarks | Mar 3 '25 | Sell | $1.41 | 6,486 | $9,125.80 | 1,497,695 | |
| HENRY CHRISTIAN O | PACB | See Remarks | Mar 3 '25 | Sell | $1.41 | 12,497 | $17,583.28 | 2,225,357 |
Latest Pacific Biosciences of California Inc. News
PACB Breaking Stock News: Dive into PACB Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy
GlobeNewswire
4 days ago
PacBio to Present at Upcoming Investor Conferences
StockStory
6 days ago
3 Out-of-Favor Stocks Skating on Thin Ice
GlobeNewswire
10 days ago
PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene
StockStory
18 days ago
1 Russell 2000 Stock with Exciting Potential and 2 to Approach with Caution
GlobeNewswire
20 days ago
PacBio Board Independent Investigation Concludes Allegations Unsubstantiated
Simply Wall St.
22 days ago
Pacific Biosciences of California First Quarter 2025 Earnings: EPS Misses Expectations
Zacks
23 days ago
PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates
Compare PACB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PACB Pacific Biosciences of California Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.